Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Hangzhou Just Biotherapeutics Opens R&D Center and GMP Manufacturing Facility to Develop Biologic Medicines Globally
2018-01-22 23:00
Adlai Nortye Enters into Global Licensing Agreement with Eisai for EP4 Antagonist
2018-01-19 21:45
WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer
2018-01-15 08:10
NeuClone Discloses Details of its Fifth Product: A Biosimilar Candidate for Prolia/XGEVA (Denosumab)
2018-01-09 00:00
China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference
2018-01-08 21:00
China Biologic Announces Corporate Update
2018-01-08 21:00
Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery
2018-01-04 10:23
Foresee Pharmaceuticals and Megapharm Announce License and Distribution Agreement
2018-01-03 20:02
China Biologic Announces Completion of Acquisition of TianXinFu from PWM
2018-01-03 19:00
CStone's anti-CTLA-4 antibody CS1002 filed for clinical trial approval in Australia
2017-12-29 21:00
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
2017-12-25 19:50
Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization
2017-12-23 01:05
Shineco, Inc. Announces $51 Million USD Contract with Horgos Huajing Tencel Technology Development Co., Ltd.
2017-12-18 21:00
China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province
2017-12-15 21:30
Shineco, Inc. Announces RMB 8 Million Contract with Huangpu International Limited
2017-12-14 02:00
Tessa Therapeutics Appoints Mr. Desmond Lim as Chief Financial Officer
2017-12-12 09:01
Biostar Regains Compliance with NASDAQ Continued Listing Requirement
2017-12-05 05:30
Foresee Pharmaceuticals Announces Results from Phase 1 Clinical Studies
2017-12-04 23:06
I-Mab Biopharma Partners with MorphoSys on Cancer Investigational Medicine
2017-12-01 15:55
ImmunoMet Appoints Briggs W. Morrison, M.D., and Paul Lammers, M.D., M.Sc., to Board of Directors
2017-11-28 21:00
1
142
143
144
145
146
165